Home › Therapeutic areas › Neurology › Parkinson's Disease

Parkinson's Disease (13 companies)

Companies with an active program in Parkinson's Disease.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
ACIU AC Immune Neurology Rare 2 Phase 3 $210M 11
ATHE Alterity Therapeutics Neurology Rare 1 Phase 2 $35.7M 2
ANRO Alto Neuroscience Neurology 1 Phase 2 $999M 6
ARVN Arvinas NeurologyOncology Rare 1 Approved $447M 10
CLNN Clene Neurology Rare 1 NDA Submitted $46.4M 5
GANX Gain Therapeutics MetabolicNeurology Rare 2 Phase 1 $52.5M 5
MGTX MeiraGTx ImmunologyMetabolic+2 Rare 1 Phase 3 $827M 16
NRSN NeuroSense Therapeutics Neurology Rare 1 Phase 2 $2.9M 3
OMER Omeros HematologyNeurology+2 Rare 1 Approved $1.04B 6
PMN ProMIS Neurosciences Neurology Rare 1 Phase 1 $28.9M 9
RVPH Reviva Pharmaceuticals CardiovascularDermatology+3 Rare 1 Phase 3 $4.7M 11
VNDA Vanda Pharmaceuticals CardiovascularDermatology+6 Rare 1 Approved $230M 27
VYGR Voyager Therapeutics MetabolicNeurology Rare 1 Phase 1 $94.6M 9